We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Catherine
Hargrave
catherine.hargrave@nihr.ac.uk
Ifra
Ali
ifra.ali.3@warwick.ac.uk
Deepali
Bij
deepali.bij@nihr.ac.uk
Ifra
Ali
ifra.ali.3@warwick.ac.uk
Ifra
Ali
ifra.ali.3@warwick.ac.uk
Diabetes mellitusOther maternal disorders predominantly related to pregnancy
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
What is the problem?
Gestational Diabetes Mellitus (GDM) is a type of diabetes that women can develop during pregnancy. Many women who develop GDM are likely to develop Type 2 diabetes (T2DM) after they give birth. South Asian women - including those from Indian, Bangladeshi, Pakistani and Sri Lankan background in the UK are more likely to develop GDM and T2DM compared to other ethnic groups, due to a mix of factors such as genetics, lifestyles and how they use healthcare services. Research has shown British-Pakistani women (BPW) have an increased risk of developing GDM and T2DM afterwards compared to some other ethnic groups. However, past research has grouped all South Asian women together - this means we do not fully understand the specific experiences and needs of BPW with GDM which may be contributing to their high risk of developing T2DM after pregnancy. This insight could help improve their GDM care and outcomes.
What will we do?
Our study aims to address the information gap we have about BPW with GDM, to help us understand how we can improve their care and outcomes, including their future high risk of T2DM. The study has four work packages:
1. Survey BPW who have GDM (or recently had) to understand what they know about the condition (work package 1).
2. NHS Diabetes Prevention Programme: We will use data from NHS England to see how many BPW join and complete this programme after pregnancy. The programme gives lifestyle support to prevent type 2 diabetes, and all women with GDM are referred to it after birth (work package 2).
3. Interview BPW and healthcare professionals about their experiences with GDM (work package 3).
4. Hold workshops with BPW and healthcare staff to discuss our findings and produce recommendations for how GDM care could be improved for this community (work package 4).
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cross-sectional;
You can take part if:
You may not be able to take part if:
WP1: Women who are under the age of 18 years. Women who do not identify as British-Pakistani and are not residing in the UK. Women who had a GDM pregnancy over 12 months ago. WP2: Women who do not meet the inclusion criteria will not be included in the dataset. WP3: Women who are under the age of 18 years. Women who do not identify as British-Pakistani and are not residing in the UK. Women who had a GDM pregnancy over 3 years ago. HCPs who are not directly or indirectly involved in GDM care.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Ifra
Ali
ifra.ali.3@warwick.ac.uk
Catherine
Hargrave
catherine.hargrave@nihr.ac.uk
Ifra
Ali
ifra.ali.3@warwick.ac.uk
Deepali
Bij
deepali.bij@nihr.ac.uk
Ifra
Ali
ifra.ali.3@warwick.ac.uk
The study is sponsored by University of Warwick and funded by NIHR Academy .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 72618
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
